CompletedNot Applicable

Surgical Management of Stage-2 MRONJ With Transplantation of HAM

Turkey (Türkiye)14 participantsStarted 2020-01-15

Plain-language summary

Medication-related osteonecrosis of the jaw (MRONJ) is a drug adverse reaction and there is no consensus for the treatment of MRONJ. The aim of this study is to evaluate the mucosal coverage using HAM after sequestrectomy in patients with stage-2 MRONJ.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: For Donors: * Free of infections such as HIV, hepatitis B and C, and syphilis before and 6 months after the cesarean section * Volunteers over the age of 18 For Recipients: • Medication-related osteonecrosis of the jaw cases with stage-2 diagnosis Exclusion Criteria: For Donors: * Any infection described above. * Mentally retarded individuals For Recipients: * MRONJ cases with stage-1, and stage-3 diagnosis * Mentally retarded individuals

What they're measuring

Change in mucosal coverage

Timeframe: 12 weeks

Trial details

NCT IDNCT04967963

SponsorTrakya University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-15

View on ClinicalTrials.gov More Medication Related Osteonecrosis of the Jaw trials